|
(Natural News) Pfizer and Merck & Co announced new trials for their new experimental oral antiviral drugs for COVID-19. The companies are looking to develop an easy-to-administer treatment for the disease. Pfizer said that its trial will enroll 1,140 non-hospitalized adults diagnosed with the SARS-CoV-2 infection who are not at risk of severe illness. The… |